joint Meeting Timetable

Thursday, October 5, 2023
Hall A
Hematology (IACH)
09:00-09:30 Welcome Coffee
09:30-12:30 Cutting Edge Cases and Controversies: A Workshop in Transplant Excellence
Industry-supported Workshop by Jazz Pharmaceuticals, On-Site only
12:30-13:00 Lunch Pick-up and Break
13:00-14:30 IACH Lunch Session: Chronic GVHD: from biology to therapy
14:30-14:45 Technical Break
14:45-16:25 IACH Session: Advances in hematology (Part 1)
16:25-16:45 Coffee Break
16:45-18:30 IACH Session: Advances in hematology (Part 2)
18:30-19:30 Opening Lectures and Awards Session
19:30 Meeting Welcome Reception
Friday, October 6, 2023
Hall A
Hall B
Hall C
MDS-AML-ALL (COMydAL)
Lymphoma (COLYM)
Myeloproliferative Neoplasms (MPNCo&D)
07:45-08:00 Welcome Coffee
08:00-09:00 Shifting the treatment paradigm in myelofibrosis: What to expect from combination therapies
Industry-supported Morning Symposium by Menarini Stemline
09:00-09:15 Technical Break
09:15-10:45 Session 1:
Classification, risk stratification & response assessment updates for MDS
Session 1:
What’s new in the field of lymphomas? Keynote lectures
Session 1:
Polycythemia Vera in 2023 and beyond
10:45-11:15 Coffee Break
11:15-12:45 Session 2:
Management of lower risk MDS
Session 2:
CLL and Richter’s syndrome
Session 2:
Essential thrombocytosis – Can we do better?
12:45-13:15 Lunch Pick-up and Break
13:15-14:30 IACH Lunch Session:
State-of-the-art in the management of …

Raising the Bar in Cytopenic Myelofibrosis
Industry-supported Lunch Symposium by GSK
(starting at 13:00)
14:30-14:45 Technical Break
14:45-16:15 Session 3:
Management of higher risk MDS
Session 3:
Follicular lymphoma
Session 3:
Myelofibrosis: current and novel approaches in a rapidly developing field
16:15-16:30 Coffee Break
16:30-18:00 Session 4:
Prognosis, MRD and transplantation for AML
Session 4:
Diffuse large B cell lymphomas

Session 4:
Treatment of high-risk MF
Saturday, October 7, 2023
 Hall A
Hall B
Hall C
MDS-AML-ALL (COMydAL)
Lymphoma (COLYM)
Myeloproliferative Neoplasms (MPNCo&D)
08:30-09:00 Welcome Coffee
09:00-10:30 Session 5:
Updates in AML management in 2023 – Agents in clinic
Session 5:
Peripheral T cell lymphomas

Session 5:
AYA MPNs: pregnancy thromboses and special considerations
(ending 10:45)
10:30-11:00 Coffee Break
11:00-12:30 Session 6:
Updates in AML management in 2023 – Investigational approaches
Session 6:
Hodgkin lymphoma
Session 6:
Rare MPNs – Focus on emerging subtypes
12:30-13:00 Lunch Pick-up and Break
13:00-14:30 The future of AML treatment:
As easy as 123?

Industry-supported Lunch Symposium by Menarini Stemline
IACH Meet the Experts Session
14:30-14:45 Technical Break
14:45-16:15 Session 7:
How do I manage ALL in 2023?
COLYM Plenary Lecture
(14:45-15:15)
Session 7:
Current and future considerations in MPNs and rare hematologic malignancies: building innovative, sustainable programs across the world

Session 7:
Mantle cell lymphoma
(15:15-16:15)
16:15-16:30 Coffee Break
16:30-17:00 IACH Closing Plenary Lecture